| Patents for C07J 1 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 17 beta by a carbon atom, e.g. oestrane, androstane (4,828) |
|---|
| 12/10/2003 | EP0711169B1 Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods |
| 12/09/2003 | US6660726 Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same |
| 12/03/2003 | EP1366743A1 Use of a derivative of 7-oxydated DHEA for treating dry skin |
| 12/03/2003 | CN1129602C 11-(substituted phenyl) estra-4,9-diene derivatives |
| 12/03/2003 | CN1129601C Pseudo gensenoside Pgq and its semi synthesis and medicinal use |
| 12/02/2003 | US6656328 Process for preparation of polyhydric alcohols |
| 11/27/2003 | WO2002062302A3 Steroidal derivatives |
| 11/26/2003 | EP1363605A1 Gaba-receptor modulators for the treatment of neurodegenerative diseases of the eye |
| 11/25/2003 | US6653491 Method for producing 4,4-dimethyl-3β-hydroxypregna-8, 14-diene-21-carboxylic acid esters and intermediate products obtained by said method |
| 11/20/2003 | WO2003095470A1 Platinum complexes having antitumor activity |
| 11/20/2003 | US20030216588 Purification of 7alpha-hydroxydehydroepiandrosterone and derivatives thereof and solvates obtained therefrom |
| 11/20/2003 | US20030216360 Subjecting a supersaturated solution containing a steroid to wet milling while crystallizing, in order to obtain a primary particle suspension. |
| 11/20/2003 | US20030215953 Separation of cresol from mares' urine |
| 11/20/2003 | US20030215516 Wet milling saturated solutions containing drugs such as steroids, while crystallizing to obtain microstructure particles in suspension |
| 11/20/2003 | CA2485431A1 Platinum complexes having antitumor activity |
| 11/19/2003 | EP1362057A1 Methods for preparing 7alpha-hydroxy-dehydroepiandrosterone |
| 11/19/2003 | CN1128154C New organic compound 4-androstene-3 beta, 17 beta-doil bis (ethylcarbonyldioxy) ester and its prepn |
| 11/18/2003 | US6649779 Estrenes |
| 11/13/2003 | WO2003093292A1 17α-FLUOROALKYL-11β-BENZALDOXIME-STEROIDS, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS CONTAINING SAID STEROIDS AND THE USE THEREOF IN THE PRODUCTION OF MEDICAMENTS |
| 11/13/2003 | WO2003092722A1 7-HYDROXY-16α-FLUORO-5-ANDROSTEN-17-ONES AND 7-HYDROXY-16α-FLUORO-5-ANDROSTAN-17-ONES AND DERIVATIVES THEREOF |
| 11/13/2003 | CA2484963A1 7-hydroxy-16a-fluoro-5-androsten-17-ones and 7-hydroxy-16a-fluoro-5-androstan-17-ones and derivatives thereof |
| 11/12/2003 | EP1360960A1 Use of ketoconazole and related substances in medicaments for treatment of type II diabetes |
| 11/11/2003 | US6645955 3,6-dihydroxy-24-amidyl steroid derivatives |
| 11/06/2003 | WO2003091272A1 Method for producing steroid crystals, crystals obtained by said method and their use in pharmaceutical formulations |
| 11/06/2003 | WO2003090721A2 Method for producing crystals from active ingredients in medicaments, and the use thereof in pharmaceutical formulations |
| 11/06/2003 | WO2003026589A3 Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides |
| 11/06/2003 | US20030207855 Compositions of matter including compounds of the present invention are also provided as are methods of treating mammals in need of treatment using compounds of the present invention. |
| 11/06/2003 | CA2480130A1 Method for producing crystals from active ingredients in medicaments and the use thereof in pharmaceutical formulations |
| 11/05/2003 | EP0994713B1 USE OF A 7alpha-METHYL-17alpha-ETHYNYL-ESTRANE DERIVATIVE FOR THE TREATMENT OF ATHEROSCLEROSIS |
| 11/05/2003 | EP0715517B1 Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions |
| 11/05/2003 | CN1453288A Catalytic dehydrogenation process of preparing Exemestane |
| 10/23/2003 | WO2003087120A1 Estrone derivative and process for producing the same |
| 10/22/2003 | EP1353938A1 Androgenic 7-substituted 11-halogenated steroids |
| 10/22/2003 | EP1056460B1 Pharmaceutical preparations for selectively supplementing oestrogen deficiency in the central nervous system |
| 10/16/2003 | WO2003084978A1 Steroidal quinols as prodrugs of antioxidants |
| 10/16/2003 | US20030195180 Estrogenic compounds as anti-mitotic agents |
| 10/15/2003 | EP1351971A2 Compounds useful for treating hypertriglyceridemia |
| 10/09/2003 | WO2003082895A2 Process to prepare eplerenone |
| 10/09/2003 | WO2003082894A2 C-17 spirolactonization and 6,7 oxidation of steroids |
| 10/09/2003 | WO2002078682A3 Estrogen replacement therapy |
| 10/09/2003 | US20030191099 Antiestrogen compound |
| 10/09/2003 | CA2480151A1 C-17 spirolactonization and 6,7 oxidation of steroids |
| 10/09/2003 | CA2474072A1 Process to prepare eplerenone |
| 10/08/2003 | CN1446817A 7 alpha-hydroxy dehydroisoandrosterone and its derivative purifying process and obtained solvate |
| 10/07/2003 | US6630577 Useful for producing bioconjugates |
| 10/02/2003 | WO2003080642A1 11beta-substituted 19-nor-17alpha-pregna-1,3,5(10)-trien-17beta-ols with a 21,16alpha-lactone ring |
| 10/02/2003 | WO2003080641A1 19-nor-17alpha-pregna-1,3,5(10)-trien-17beta-ols with a 21,16alpha-lactone ring substituted with a long chain at the 11beta position |
| 10/02/2003 | WO2003079961A2 Method for producing 7$g(a)-methyl steroids |
| 10/02/2003 | US20030186945 Method of preparing and use of prodrugs of betulinic acid derivatives |
| 10/01/2003 | CN1446086A Use of estramustine phosphate in treatment of bone metastasis |
| 09/30/2003 | CA2114630C Steroid sulphatase inhibitors |
| 09/25/2003 | US20030181435 Systemic lupus erythematosus therapy |
| 09/24/2003 | EP1346997A1 Process for the purification of 7-alpha-hydroxy-dehydroepiandrosteron and derivatives thereof, and solvates obtained |
| 09/24/2003 | CN1444596A 16 alpha-methyl or ethyl substituted estrogens |
| 09/23/2003 | US6623933 Methods for identifying a subunit specific modulator of N-methyl-D-asparate receptor |
| 09/23/2003 | CA2073760C Steroidal organic substance crystallization method and compounds thereby obtained |
| 09/23/2003 | CA2062973C Combination therapy for prophylaxsis and/or treatment of benign prostatic hyperplasia |
| 09/18/2003 | US20030176405 8 Beta-hydrocarbyl-substituted estratrienes for use as selective estrogens |
| 09/18/2003 | US20030175751 Having substituents such as steroids, reporter molecules/enzymes, non-aromatic lipophilic molecules, peptides, or proteins attached via linking groups; improved diagnosis |
| 09/17/2003 | EP1343804A1 14(15)-unsaturated 15- and/or 16- substituted androgens with mixed androgen-progestational profile |
| 09/17/2003 | EP1343803A2 2-substituted estrogens as antiangiogenic agents |
| 09/17/2003 | EP1343508A1 Use of an oestrogen in the manufacture of a composition containing oestrogen for the treatment of atrophic vaginitis |
| 09/16/2003 | US6620802 Methods of treating mild cognitive impairment using a glucocorticoid-specific receptor antagonist |
| 09/16/2003 | US6620801 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 09/16/2003 | CA2019404C 11 beta-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents |
| 09/11/2003 | US20030171345 8Beta-substituted 11beta-aryl-estra-1,3,5,(10)-triene derivatives |
| 09/10/2003 | CN1120843C Isomerisation of equilin |
| 09/04/2003 | WO2003072110A1 Use of biogenic estriol diester prodrugs for the treatment of autoimmune diseases |
| 09/04/2003 | WO2003032961A3 Methods for preventing and treating bone loss with steroid compounds |
| 09/04/2003 | US20030166626 7-Hydroxyepiandrosterone having neuroprotective activity |
| 09/03/2003 | EP1340502A2 Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods |
| 09/03/2003 | EP1339734A2 Method for the production of 4-(17alpha substituted 3-oxoestra-4,9-dien-11-yl)benzaldehyd-(1e or 1z)-oximes |
| 09/03/2003 | EP1339733A2 Method for the production of 4-(17alpha-methyl substituted 3-oxoestra-4,9-dien-11-yl)benzaldehyd-(1e or 1z)-oximes |
| 09/03/2003 | EP0973792B1 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives |
| 09/03/2003 | CN1440290A 7-Hydroxyepiandrosterone having neuroprotective activity |
| 09/03/2003 | CN1439673A High friction coefficient rubber composite brake shoes |
| 09/03/2003 | CN1439375A 脱氢表雄酮的治疗用途和传送系统 DHEA therapeutic uses and delivery systems |
| 08/26/2003 | US6610844 Removing an 11-alpha-leaving group from an epoxymexrenone derivative |
| 08/21/2003 | US20030158166 Administration of an anticancer (7-alpha-9-(4,4,5,5,5-pentafluoropentylsulphinyl)nonyl)-estra-1,3,5,-(10) triene-3,17-diol to a breast cancer patient previously treated with an aromatase inhibitor and failed |
| 08/21/2003 | US20030158164 Novel antiandrogenic agent |
| 08/19/2003 | US6607757 At least 13% glucoside isoflavones and 0.6-1.5 parts 3 soya saponins per 1 part by weight of glucoside isoflavones; treating pre or post menopausal symptoms, breast and prostate cancer, and alcoholism |
| 08/14/2003 | US20030153544 Fatty acid derivatives |
| 08/13/2003 | EP1334725A2 Estroprogestative contraceptive composition |
| 08/13/2003 | CN1436170A Vitamin D derivs. |
| 08/13/2003 | CN1117759C Steroid, its preparation method, medicine composition and use thereof |
| 08/12/2003 | US6605622 Use of anti-estrogenic compounds as anti-fungal agents |
| 08/07/2003 | WO2003000271A8 System and method for the large scale labeling of compounds with radiohalogens |
| 08/06/2003 | EP1212345B1 Orally active 7-alpha-alkyl androgens |
| 07/31/2003 | US20030144259 Exemestane for use in the first-line treatment of metastatic, advanced hormone-dependent breast cancer, particularly in post-menopausal woman; endorcine therapy |
| 07/30/2003 | EP1330467A2 Modified, hydroxy-substituted aromatic structures having cytoprotective activity |
| 07/30/2003 | CN1433424A 8 Beta-hydrocarbyl-substituted estratrienes for use as selective estrogens |
| 07/29/2003 | CA2057747C Contraceptive regimen |
| 07/24/2003 | WO2003059931A1 PROCESS FOR THE PREPARATION OF 7α-METHYLSTEROIDS |
| 07/24/2003 | US20030139384 Transdermal supplying testosterone |
| 07/23/2003 | EP1328264A1 Use of estramustine phosphate in the treatment of bone metastasis |
| 07/23/2003 | CN1431905A Use of fulvestrant in treatment of resistant breast cancer |
| 07/22/2003 | US6596319 Such as various cancers, by administering low molecular weight compounds of following properties: extractable from bile of an animal, stimulates monocytes and macrophages, modulates tumor necrosis factor production, not endotoxin |
| 07/17/2003 | US20030134834 Antigestagenically active steroids with a fluorinated 17-alpha-alkyl chain |
| 07/17/2003 | US20030134831 Parent androgen has a skeletal structure including a 4 position and a 17 position. It has a 17 beta -hydroxy group that includes a 17 beta -hydroxy oxygen appended to the 17 position and a 17 beta -hydroxy hydrogen appended to the 17 |
| 07/15/2003 | US6593321 Compounds to inhibit undesired cell proliferation and tumor growth. Additionally, methods are disclosed of treating diseases associated with undesired angiogenesis and undesired proliferation, and methods of treating infectious disease |